"COVID-19 UPDATE: St. Joseph's Hospital currently has visitor restrictions in place. Patients will be allowed only one designated visitor a day. This person will need to be an immediate family member or the primary care taker (note: there are no visitors allowed on our skilled nursing units). Visitors will be asked to sign in each day at each hospital lobby and will be issued a visitor pass. Please help us encourage other extended family members to use other means of communication. If you have flu-like symptoms or symptoms consistent with COVID-19, do not visit any patients. You will only be allowed in for treatment."

During the past decade, St Joseph's/Candler Health System conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 11 clinical trials were completed, i.e. on average, 366.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Joseph's/Candler Health System" #1 sponsor was "Radiation Therapy Oncology Group" with 4 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "H. Lee Moffitt Cancer Center and Research Institute" with 2 trials sponsored and "Millennium Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Joseph's/Candler Health System" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "St Joseph's/Candler Health System" are "Breast Cancer" (4 trials), "Cervical Cancer" (3 trials), "Prostate Cancer" (3 trials), "Colon Cancer" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "St Joseph's/Candler Health System" in a lesser frequency.

Most popular intervention types in "St Joseph's/Candler Health System" are "Drug" (22 trials), "Biological" (5 trials), "Device" (4 trials), "Radiation" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Bevacizumab" (2 trials), "cetuximab" (2 trials), "fluorouracil" (2 trials) and "gemcitabine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "St Joseph's/Candler Health System" are 28 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St Joseph's/Candler Health System". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in St Joseph's/Candler Health System, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in St Joseph's/Candler Health System, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

St Joseph's/Candler Health System has several departments that took part in Clinical trials: "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" - 264 trials, "South Carolina Cancer Specialists PC" - 53 trials, "The Radiation Oncology Center-Hilton Head/Bluffton" - 20 trials